GENESPIRE
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.
GENESPIRE
Industry:
Biotechnology Life Science
Founded:
2020-03-01
Address:
Milan, Lombardia, Italy
Country:
Italy
Website Url:
http://www.genespire.com
Total Employee:
1+
Status:
Active
Contact:
39 02 83991300
Email Addresses:
[email protected]
Total Funding:
16 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sofinnova Partners
Sofinnova Partners investment in Series A - Genespire
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-07 | Genespire appoints Dr. Sabah Sallah as Chief Medical Officer |
Official Site Inspections
http://www.genespire.com
- Host name: carnage.evtel.com
- IP address: 18.156.43.197
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Genespire"
The company - Genespire
Genespire is led by an experienced and international management team with experience from renowned biotech companies and world-class …See details»
Genespire - Crunchbase Company Profile & Funding
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.See details»
Genespire - LinkedIn
Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary …See details»
Genespire 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Genespire. Use the PitchBook Platform to explore the full profile.See details»
Genespire - Funding, Financials, Valuation & Investors
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.See details»
Genespire - Milano, Italy
Oct 1, 2024 Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary …See details»
Genespire s.r.l. - VentureRadar
"At Genespire we develop first-in-class gene therapies with the aim of curing people affected by severe diseases. Our therapies are based on proprietary advanced lentiviral vector platforms …See details»
Our science - Genespire
Our candidate products respond to actual unmet medical needs and are designed to enhance both the safety and efficacy profile of gene therapy. Genespire Srl Genespire’s mission is to …See details»
Genespire - Contacts, Employees, Board Members, Advisors
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.See details»
Genespire | The Pharmaletter
Sep 25, 2024 Genespire is developing gene therapies based on immune shielded lentiviral vectors (ISLVs) that are designed to be used intravenously and allow the life-long production …See details»
Genespire Company Profile - Office Locations, Competitors ... - Craft
Genespire has 5 employees at their 1 location and $17.34 m in total funding,. See insights on Genespire including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Genespire - Sofinnova Partners
Sep 11, 2024 Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary …See details»
Genespire | Biotech Careers
Genespire’s mission is to enable children affected by genetic diseases to benefit from the life-changing potential of gene therapy. Business Areas: Cell and Gene TherapySee details»
Genespire Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Genespire. See Genespire company profile and funding data.See details»
Overview - Genespire
Genespire has generated a novel proprietary class of lentiviral vectors, the Immune Shielded Lentiviral Vectors (ISLVs), which are masked from the patient’s immune system.See details»
Genespire raises €46.6 million (~$52 million) in a Series ... - BioSpace
Sep 25, 2024 About Genespire Genespire is a biotechnology company, developing off-the-shelf gene therapies based on immune shielded lentiviral vectors (ISLVs) for pediatric patients …See details»
Genespire: boosting gene therapy efficiency, efficacy
May 11, 2021 San Raffaele gene therapy spinout Genespire is deploying gene editing and delivery platforms to develop therapies for primary immunodeficiencies and inherited metabolic …See details»
Genespire raises $52m in Series B to trial paediatric gene therapy
Sep 25, 2024 The funds will advance Genespire’s gene therapy for methylmalonic acidemia, a group of rare metabolic disorders, to Phase I/II trials.See details»
Programs - Genespire
Genespire’s ISLV-based gene therapy presents a distinct alternative, offering a one-time treatment option accessible to pediatric patients who represent the majority of MMA patients.See details»
DNA organization offers clues for advancing stem cell therapy
3 days ago DNA organization offers clues for advancing stem cell therapy UC Riverside-led study could help advance treatments for injuries, aging, and diseasesSee details»